GALLANT: Inspiring Local Champions, Awakening Global Potential

GALLANT is here to inspire local champions and awaken global potential. The time to step up is now.

Tala PH Strengthens Commitment To Empowered, Gender-Inclusive Workplace

Tala continues to uphold its mission to create an empowered and gender-inclusive workplace.

Wyeth Nutrition Drives Sustainability Practices In Nourishing Healthier Tomorrows

Wyeth Nutrition is dedicated to enhancing sustainability practices that support healthier futures for families.

Residential Condo Development Set To Elevate Bacolod Living In Saludad Township

A new residential condo development in Saludad Township is set to redefine living in Bacolod.

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.

Turkish Scientists Begin Testing Drug To Treat Advanced Cancer

36
36

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

Turkish scientists have begun the Phase 1 studies of a drug developed for patients with recurrent, metastatic, or advanced lung cancer.

The Phase 1a study will involve 16 volunteers in total, and the researchers will determine the maximum tolerable dose for patients, while the Phase 1b study will focus on the medication’s efficacy and safety in 10 other patients.

Rana Nomak Sanyal, a chemistry professor at Bogazici University, and her team have developed the medicine.

Fevzi Altuntas, who is in charge of the Phase 1a research at Ankara Oncology Training and Research Hospital, told Anadolu Agency that scientists are working together to ensure that Turkiye has self-sufficiency in health to the level where it can develop its own medicines.

“The drug will be a beacon of hope for people with lung cancer. A new molecule, a targeted agent,” he said, adding that patients who tried standard treatments without success could benefit from the cure.

Altuntas added the hospital’s Clinical Research Center has taken on significant responsibilities at both the national and international levels.

He highlighted that the research center has conducted a number of studies, including 114 international Phase 2 and Phase 3 studies, a national virus-like particle (VLP) vaccine, Car-T-cell therapy, and seven Phase 1 cancer trials. (PNA)